38 related articles for article (PubMed ID: 32811645)
1. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
Cui X; Chen Y; Zhao L; Ding X
Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p.
Cui Z; Pu T; Zhang Y; Wang J; Zhao Y
Open Biol; 2020 May; 10(5):190286. PubMed ID: 32397872
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
[TBL] [Abstract][Full Text] [Related]
5. IP3R1 dysregulation via mir-200c-3p/SSFA2 axis contributes to taxol resistance in head and neck cancer.
Sanli F; Tatar A; Gundogdu B; Karatas OF
Eur J Pharmacol; 2024 Jun; 973():176592. PubMed ID: 38642666
[TBL] [Abstract][Full Text] [Related]
6. Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.
Dugina V; Vasileva M; Khromova N; Vinokurova S; Shagieva G; Mikheeva E; Galembikova A; Dunaev P; Kudlay D; Boichuk S; Kopnin P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674115
[TBL] [Abstract][Full Text] [Related]
7. The nature of the modification at position 37 of tRNAPhe correlates with acquired taxol resistance.
Pan Y; Yan TM; Wang JR; Jiang ZH
Nucleic Acids Res; 2021 Jan; 49(1):38-52. PubMed ID: 33290562
[TBL] [Abstract][Full Text] [Related]
8. RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M; Rodríguez-Acebes S; Blondeau J; Parent MA; Zocco M; Song Y; de Maertelaer V; Moers V; Latil M; Dubois C; Coulonval K; Impens F; Van Haver D; Dufour S; Uemura A; Sotiropoulou PA; Méndez J; Blanpain C
Nature; 2023 Apr; 616(7955):168-175. PubMed ID: 36949199
[TBL] [Abstract][Full Text] [Related]
9. Ugonin P inhibits lung cancer motility by suppressing DPP-4 expression via promoting the synthesis of miR-130b-5p.
Wu CY; Ghule SS; Liaw CC; Achudhan D; Fang SY; Liu PI; Huang CL; Hsieh CL; Tang CH
Biomed Pharmacother; 2023 Nov; 167():115483. PubMed ID: 37703658
[TBL] [Abstract][Full Text] [Related]
10. The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma.
Xu H; Li W; Wang D
Front Oncol; 2024; 14():1299249. PubMed ID: 38482204
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNA actions through IGFs and IGF binding proteins in cancer.
Kerr A; Baxter RC
Oncogene; 2022 Jun; 41(25):3385-3393. PubMed ID: 35597813
[TBL] [Abstract][Full Text] [Related]
12. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors.
Zeng X; Li Z; Zhu C; Xu L; Sun Y; Han S
Drug Deliv; 2021 Dec; 28(1):2329-2347. PubMed ID: 34730054
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
Peng F; Fan H; Li S; Peng C; Pan X
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
[TBL] [Abstract][Full Text] [Related]
14. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
15. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
16. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
17. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
18. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
19. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
Ashrafizadeh M; Mirzaei S; Hashemi F; Zarrabi A; Zabolian A; Saleki H; Sharifzadeh SO; Soleymani L; Daneshi S; Hushmandi K; Khan H; Kumar AP; Aref AR; Samarghandian S
Biomed Pharmacother; 2021 Sep; 141():111824. PubMed ID: 34175815
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
